scrutnizer report
Awaiting price reaction for this filing.
MPS Pharmaa Limited (formerly Advik Laboratories Limited) held its 31st Annual General Meeting on September 29, 2025, at its registered office in Sohna, Haryana, at 9:30 AM. Four resolutions were put to vote through a combination of e-voting and physical poll, and all were passed with 100% approval and zero dissent. Resolution 1 covered adoption of the audited financial statements for FY ending March 31, 2025, with 1,13,86,384 shares voting in favor. Resolution 2 approved the re-appointment of Mr. Peeyush Kumar Aggarwal (DIN:00090423) as a director liable to retire by rotation, with 94,27,925 shares in favor. Resolution 3 approved related party transactions under Section 188 of the Companies Act, 2013 and SEBI LODR Regulation 23, with 45,25,593 shares in favor (three related parties abstained). Resolution 4 approved the appointment of the Secretarial Auditor, with 1,13,86,384 shares in favor. The Scrutinizer, Mr. Kundan Agrawal (Practicing Company Secretary), confirmed that all resolutions were passed with the requisite majority.
This is a routine regulatory filing confirming that all AGM resolutions were passed unanimously, indicating strong shareholder support for management's proposals. No negative signals for shareholders; the related party transaction approval is the only item of note but was passed cleanly. The company name change from Advik Laboratories to MPS Pharmaa is already reflected in the document.